Venture Firm Executives Get Suspended Terms for Bio Stock Fraud
Venture investment firm executives received suspended prison terms for inflating a KOSDAQ-listed firm's stock with fake bio-drug news, pocketing over 35 billion won in illicit gains.
Read the full articleYou might also wanna read
Biotech venture capital roundup: Osanni Bio leads with $190M Series B
Our latest roundup of venture capital financings in the biotech sector includes rounds for Osanni Bio, Bionyra, Serapha, Nura Bio, and Oblen
pharmaphorum.com·21d ago
US biotechs turn secretive as they fear competition from rising Chinese industry
US biotechs turn tight-lipped on gene targets and pipelines as China's fast-follower threat intensifies, 20+ founders and investors tell End
endpoints.news·6d agoThe Indian Competition Authority fines an investment manager for failing to notify its acquisition of convertible debentures in a biopharmaceutical company and rejects the minority investment exemption over board-minutes access and facility visit rights (
Background On 14 January 2025, the Competition Commission of India (“CCI”) imposed a penalty of INR 40 lakhs on Goldman Sachs (India) Altern
Biogen Is Paying $1 Billion for a Company That Won't Say What It Makes. Here's Why That's Actually Good News for BIIB Investors.
This could be a key move for future growth.
AI startup CEO pleaded guilty in US to trading on insider tips from lawyers
He traded on confidential merger information passed along by lawyers. Prosecutors recommended a two-year prison sentence and forfeiture of p
AI startup CEO pleaded guilty in US to trading on insider tips from lawyers
He traded on confidential merger information passed along by lawyers. Prosecutors recommended a two-year prison sentence and forfeiture of p
San Francisco CEO Gets 6 Years for Scheme to Sell Adderall Online
The pair of conspirators face up to 20 years in prison over their scheme to fraudulently distribute Adderall, Vyvanse and ...
Comments
Sign in to join the conversation.
No comments yet. Be the first.